Genetic disorder
Genetic disorder |
Classification and external resources |
MeSH |
D030342 |
A genetic disorder is an illness caused by abnormalities in genes or chromosomes. While some diseases, such as cancer, are due in part to genetic disorders, they can also be caused by environmental factors. Most disorders are quite rare and affect one person in every several thousands or millions. Some types of recessive gene disorders confer an advantage in the heterozygous state in certain environments.[1]
Single gene disorder
Prevalence of some single gene disorders
Disorder |
Prevalence (approximate) |
Autosomal dominant |
Familial hypercholesterolemia |
1 in 500 |
Polycystic kidney disease |
1 in 1250 |
Hereditary spherocytosis |
1 in 5,000 |
Marfan syndrome |
1 in 4,000 [2] |
Huntington disease |
1 in 15,000 [3] |
Autosomal recessive |
Sickle cell anemia |
1 in 625
(African Americans) |
Cystic fibrosis |
1 in 2,000
(Caucasians) |
Tay-Sachs disease |
1 in 3,000
(American Jews) |
Phenylketonuria |
1 in 12,000 |
Mucopolysaccharidoses |
1 in 25,000 |
Glycogen storage diseases |
1 in 50,000 |
Galactosemia |
1 in 57,000 |
X-linked |
Duchenne muscular dystrophy |
1 in 7,000 |
Hemophilia |
1 in 10,000 |
Values are for liveborn infants |
A single gene disorder is the result of a single mutated gene. There are estimated to be over 4000 human diseases caused by single gene defects. Single gene disorders can be passed on to subsequent generations in several ways. Genomic imprinting and uniparental disomy, however, may affect inheritance patterns. The divisions between recessive and dominant types are not "hard and fast" although the divisions between autosomal and X-linked types are (since the latter types are distinguished purely based on the chromosomal location of the gene). For example, achondroplasia is typically considered a dominant disorder, but children with two genes for achondroplasia have a severe skeletal disorder that achondroplasics could be viewed as carriers of. Sickle-cell anemia is also considered a recessive condition, but heterozygous carriers have increased resistance to malaria in early childhood, which could be described as a related dominant condition. When a couple where one partner or both are sufferers or carriers of a single gene disorder and wish to have a child they can do so through IVF whichs means they can then have PGD (pre-implantation genetic diagnosis) to check whether the fertilised egg has had the genetic disorder passed on.[4]
Autosomal dominant
Only one mutated copy of the gene will be necessary for a person to be affected by an autosomal dominant disorder. Each affected person usually has one affected parent. There is a 50% chance that a child will inherit the mutated gene. Conditions that are autosomal dominant often have low penetrance, which means that although only one mutated copy is needed, a relatively small proportion of those who inherit that mutation go on to develop the disease. Examples of this type of disorder are Huntington's disease, neurofibromatosis type 1, Marfan syndrome, hereditary nonpolyposis colorectal cancer, and hereditary multiple exostoses, which is a highly penetrant autosomal dominant disorder. Birth defects are also called congenital anomalies.
Autosomal recessive
Two copies of the gene must be mutated for a person to be affected by an autosomal recessive disorder. An affected person usually has unaffected parents who each carry a single copy of the mutated gene (and are referred to as carriers). Two unaffected people who each carry one copy of the mutated gene have a 25% chance with each pregnancy of having a child affected by the disorder. Examples of this type of disorder are cystic fibrosis, sickle-cell disease (also partial sickle-cell disease), Tay-Sachs disease, Niemann-Pick disease, spinal muscular atrophy, Roberts syndrome, and Dry (otherwise known as "rice-brand") earwax.[5]
X-linked dominant
X-linked dominant disorders are caused by mutations in genes on the X chromosome. Only a few disorders have this inheritance pattern, with a prime example being X-linked hypophosphatemic rickets. Males and females are both affected in these disorders, with males typically being more severely affected than females. Some X-linked dominant conditions such as Rett syndrome, incontinentia pigmenti type 2 and Aicardi syndrome are usually fatal in males either in utero or shortly after birth, and are therefore predominantly seen in females. Exceptions to this finding are extremely rare cases in which boys with Klinefelter syndrome (47,XXY) also inherit an X-linked dominant condition and exhibit symptoms more similar to those of a female in terms of disease severity. The chance of passing on an X-linked dominant disorder differs between men and women. The sons of a man with an X-linked dominant disorder will all be unaffected (since they receive their father's Y chromosome), and his daughters will all inherit the condition. A woman with an X-linked dominant disorder has a 50% chance of having an affected fetus with each pregnancy, although it should be noted that in cases such as incontinentia pigmenti only female offspring are generally viable. In addition, although these conditions do not alter fertility per se, individuals with Rett syndrome or Aicardi syndrome rarely reproduce.
X-linked recessive
X-linked recessive conditions are also caused by mutations in genes on the X chromosome. Males are more frequently affected than females, and the chance of passing on the disorder differs between men and women. The sons of a man with an X-linked recessive disorder will not be affected, and his daughters will carry one copy of the mutated gene. A woman who is a carrier of an X-linked recessive disorder (XRXr) has a 50% chance of having sons who are affected and a 50% chance of having daughters who carry one copy of the mutated gene and are therefore carriers. X-linked recessive conditions include the serious diseases Hemophilia A, Duchenne muscular dystrophy, and Lesch-Nyhan syndrome as well as common and less serious conditions such as male pattern baldness and red-green color blindness. X-linked recessive conditions can sometimes manifest in females due to skewed X-inactivation or monosomy X (Turner syndrome).
Y-linked
Y-linked disorders are caused by mutations on the Y chromosome. Because males inherit a Y chromosome from their fathers, every son of an affected father will be affected. Because females inherit an X chromosome from their fathers, female offspring of affected fathers are never affected.
Since the Y chromosome is relatively small and contains very few genes, there are relatively few Y-linked disorders. Often the symptoms include infertility, which may be circumvented with the help of some fertility treatments. Examples are male infertility and hypertrichosis pinnae.
Mitochondrial
This type of inheritance, also known as maternal inheritance, applies to genes in mitochondrial DNA. Because only egg cells contribute mitochondria to the developing embryo, only mothers can pass on mitochondrial conditions to their children. An example of this type of disorder is Leber's hereditary optic neuropathy.
Multifactorial and polygenic (complex) disorders
Genetic disorders may also be complex, multifactorial, or polygenic, meaning that they are likely associated with the effects of multiple genes in combination with lifestyle and environmental factors. Multifactorial disorders include heart disease and diabetes. Although complex disorders often cluster in families, they do not have a clear-cut pattern of inheritance. This makes it difficult to determine a person’s risk of inheriting or passing on these disorders. Complex disorders are also difficult to study and treat because the specific factors that cause most of these disorders have not yet been identified.
On a pedigree, polygenic diseases do tend to “run in families”, but the inheritance does not fit simple patterns as with Mendelian diseases. But this does not mean that the genes cannot eventually be located and studied. There is also a strong environmental component to many of them (e.g., blood pressure).
Prognosis and treatment of genetic disorders
Genetic disorders rarely have effective treatments, though gene therapy is being tested as a possible treatment for some genetic diseases, including some forms of retinitis pigmentosa[6]
- Gauchers disease is a genetic disease affecting metabolism. It is more treatable then most other genetic diseases, and can be treated with enzyme replacement therapy, medication miglustat, and bone marrow transplantion.[7]
See also
References
- ↑ WGBH Educational Foundation
- ↑ Keane MG, Pyeritz RE (May 2008). "Medical management of Marfan syndrome". Circulation 117 (21): 2802–13. doi:10.1161/CIRCULATIONAHA.107.693523. PMID 18506019. http://circ.ahajournals.org/cgi/content/full/117/21/2802.
- ↑ Walker FO (2007). "Huntington's disease". Lancet 369 (9557): 221. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289.
- ↑ Kuliev A, Verlinsky Y (2005). "Preimplantation diagnosis: A realistic option for assisted reproduction and genetic practice". Curr. Opin. Obstet. Gynecol. 17 (2): 179–83. doi:10.1097/01.gco.0000162189.76349.c5. PMID 15758612. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1040-872X&volume=17&issue=2&spage=179. Retrieved 2009-04-01.
- ↑ Wade, Nicholas (January 29, 2006). "Japanese Scientists Identify Ear Wax Gene". New York Times.
- ↑ Retinitis Pigmentosa: Treatment & Medication, eMedicine WebMD, 2009-09-19, accessed 2010-03-31.
- ↑ Gaucher's disease:Treatments and drugs, eMedicine WebMD, 2009-07-11, accessed 2010-03-31.
External links
Genetic disorder, protein biosynthesis: Transcription factor/coregulator deficiencies |
|
(1) Basic domains |
1.2: Feingold syndrome · Saethre-Chotzen syndrome
1.3: Tietz syndrome
|
|
(2) Zinc finger
DNA-binding domains |
2.1 (Intracellular receptor): Thyroid hormone resistance · Androgen insensitivity syndrome (PAIS, MAIS, CAIS) · Kennedy's disease · PHA1AD pseudohypoaldosteronism · Estrogen insensitivity syndrome · X-linked adrenal hypoplasia congenita · MODY 1
2.2: Barakat syndrome
2.3: Greig cephalopolysyndactyly syndrome/Pallister-Hall syndrome · Denys–Drash syndrome · Duane-radial ray syndrome · MODY 7
2.5: Autoimmune polyendocrine syndrome type 1
|
|
(3) Helix-turn-helix domains |
3.1: Currarino syndrome · Nail–patella syndrome · SPD1 Synpolydactyly · Mowat-Wilson syndrome · Axenfeld syndrome 1 · MODY 4
3.2: Waardenburg syndrome 1 · Papillorenal syndrome
3.3: IPEX · Axenfeld syndrome 3
3.5: Van der Woude syndrome/Popliteal pterygium syndrome
|
|
(4) β-Scaffold factors
with minor groove contacts |
4.2: Hyperimmunoglobulin E syndrome
4.3: Holt-Oram syndrome · Li-Fraumeni syndrome · Ulnar–mammary syndrome
4.7: Campomelic dysplasia · MODY 3 · MODY 5
4.11: Cleidocranial dysostosis
|
|
(0) Other transcription factors |
none
|
|
Ungrouped |
Pitt-Hopkins syndrome · ZFP57 (TNDM1)
|
|
Transcription coregulators |
Rubinstein-Taybi syndrome · Atrichia with papular lesions
|
|
see also transcription factors
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|
Genetic disorder, membrane: Solute carrier disorders |
|
1-10 |
SLC1A3 (Episodic ataxia 6) · SLC2A1 (De Vivo disease) · SLC2A5 (Fructose malabsorption) · SLC2A10 (Arterial tortuosity syndrome) · SLC3A1 (Cystinuria) · SLC4A1 (Hereditary spherocytosis 4/Hereditary elliptocytosis 4) · SLC5A1 (Glucose-galactose malabsorption) · SLC5A2 (Renal glycosuria) · SLC5A5 (Thyroid dyshormonogenesis type 1) · SLC6A19 (Hartnup disease) · SLC7A7 (Lysinuric protein intolerance) · SLC7A9 (Cystinuria)
|
|
11-20 |
SLC11A1 ( Crohn's disease) · SLC12A3 (Gitelman syndrome) · SLC16A1 (HHF7) · SLC16A2 (Allan–Herndon–Dudley syndrome) · SLC17A5 (Salla disease)
|
|
21-40 |
SLC26A2 (Multiple epiphyseal dysplasia 4) · SLC26A4 (Pendred syndrome) · SLC35C1 (CDOG 2C) · SLC39A4 (Acrodermatitis enteropathica) · SLC40A1 (African iron overload)
|
|
see also
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|
Genetic disorder, membrane: cell surface receptor deficiencies |
|
G protein-coupled receptor
(including hormone) |
Class A
|
Thyrotropin receptor
|
CHNG1 congenital hypothyroidism
|
|
LH receptor
|
Male-limited precocious puberty
|
|
FSH receptor
|
XX gonadal dysgenesis
|
|
Endothelin receptor
|
ABCD syndrome
|
|
|
Class B
|
Parathyroid hormone receptor
|
Jansen's metaphyseal chondrodysplasia · Pseudohypoparathyroidism
|
|
|
Class C
|
|
Calcium-sensing receptor
|
Familial hypocalciuric hypercalcemia
|
|
|
|
Enzyme-linked receptor
(including
growth factor) |
RTK
|
ROR2: Robinow syndrome
FGFR1: Pfeiffer syndrome · KAL2 Kallmann syndrome
FGFR2: Apert syndrome · Antley-Bixler syndrome · Pfeiffer syndrome · Crouzon syndrome · Jackson-Weiss syndrome
FGFR3: Achondroplasia · Hypochondroplasia · Thanatophoric dysplasia
Insulin receptor: Donohue syndrome · Rabson–Mendenhall syndrome
|
|
STPK
|
Anti-Müllerian hormone receptor (Persistent Mullerian duct syndrome II)
TGF beta receptors: Endoglin/Alk-1/SMAD4 (Hereditary hemorrhagic telangiectasia) · TGFBR1/TGFBR2 (Loeys-Dietz syndrome)
|
|
GC
|
GUCY2D: Leber's congenital amaurosis 1
|
|
|
JAK-STAT |
Type I cytokine receptor: GH (Laron syndrome) · Granulocyte macrophage CSF (Surfactant metabolism dysfunction 4)
MPL (Congenital amegakaryocytic thrombocytopenia)
|
|
see also cell surface receptors
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|
Genetic disorder, extracellular: scleroprotein disease (excluding laminin and keratin) |
|
Collagen disease |
COL1: Osteogenesis imperfecta · Ehlers-Danlos syndrome, types 1,2,&7
COL2: Hypochondrogenesis · Achondrogenesis type 2 · Stickler syndrome · Marshall syndrome · Spondyloepiphyseal dysplasia congenita · Kniest dysplasia (see also C2/11)
COL3: Ehlers–Danlos syndrome, types 3&4 (Sack–Barabas syndrome)
COL4: Alport syndrome
COL5: Ehlers–Danlos syndrome, types 1&2
COL6: Bethlem myopathy · Ullrich congenital muscular dystrophy
COL7: Epidermolysis bullosa dystrophica · Recessive dystrophic epidermolysis bullosa · Bart syndrome
COL8: Fuchs' dystrophy
COL9: Multiple epiphyseal dysplasia 2, 3, 6
COL10: Schmid metaphyseal chondrodysplasia
COL11: Weissenbacher-Zweymüller syndrome · Otospondylomegaepiphyseal dysplasia (see also C2/11)
COL17: Bullous pemphigoid
|
|
Other |
Congenital stromal corneal dystrophy · Raine syndrome · Urbach–Wiethe disease
|
|
see also fibrous proteins
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|
Genetic disorder, membrane: Channelopathy |
|
Calcium channel |
Voltage-gated
|
Hypokalemic periodic paralysis · Timothy syndrome · Brugada syndrome 3&4 · Familial hemiplegic migraine 1 · Episodic ataxia 2 · Thyrotoxic periodic paralysis 1 · Long QT syndrome 8
|
|
Ligand gated
|
Malignant hyperthermia · Central core disease
|
|
|
Sodium channel |
Voltage-gated
|
Erythromelalgia · Hypokalemic periodic paralysis · Hyperkalemic periodic paralysis · Bartter syndrome 3&4 · Brugada syndrome 1&6 · Familial hemiplegic migraine 3 · Generalized epilepsy with febrile seizures plus · Paramyotonia congenita · Febrile seizure 3 · Long QT syndrome 3, 10
|
|
Constitutively active
|
Liddle's syndrome
|
|
|
Potassium channel |
Voltage-gated
|
Jervell and Lange-Nielsen syndrome · Romano-Ward syndrome · Brugada syndrome 5 · Episodic ataxia 1 · Short QT syndrome · Neuromyotonia/Isaacs syndrome · Long QT syndrome 1, 5, 6 · Familial atrial fibrillation 3
|
|
Inward-rectifier
|
Andersen-Tawil syndrome · Bartter syndrome 2 · Thyrotoxic periodic paralysis 2 · Long QT syndrome 7 · KCNJ11 (TNDM3)
|
|
|
Chloride channel |
Cystic fibrosis/Congenital absence of the vas deferens · Thomsen disease · Myotonia congenita · Dent's disease · Vitelliform macular dystrophy
|
|
TRP channel |
Mucolipidosis type IV · FSGS2
|
|
see also ion channels
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|
Genetic disorder, organelle: Ciliopathy |
|
Structural |
receptor: Polycystic kidney disease
cargo: Asphyxiating thoracic dysplasia
basal body: Bardet–Biedl syndrome
mitotic spindle: Meckel syndrome
centrosome: Joubert syndrome
|
|
Signaling |
Nephronophthisis
|
|
Other/ungrouped |
Alström syndrome · Primary ciliary dyskinesia · Senior-Løken syndrome · Orofaciodigital syndrome 1
|
|
see also
structural (perx, skel, cili, mito, , sclr) · DNA/RNA/protein synthesis (drep, trfc) · membrane (icha, iopu, mtrn) · transduction (csrc, ), trfk |
|